Articles On Uscom (ASX:UCM)

Australian shares rose to a two-week high as investors weighed positive overnight leads against the impact of bushfires and the coronavirus on company earnings. The ASX 200 advanced 51 points or 0.7 per cent to 7063, the index’s highest...

Two more coronavirus infections were released to the ASX in the last 24 hours, but while one was bad, it turns out the other wasn’t part of the epidemic at all. Uscom (ASX:UCM) says sales of its haemodynamic monitoring device in China, whic...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

The ongoing coronavirus outbreak in China is making itself felt in a commercial sense as medical technology company Uscom (ASX: UCM), a supplier of monitoring devices, announced a material increase in orders for its USCOM 1A device in China...

Over the past five weeks, Uscom (UCM) has received a material increase in demand for its USCOM 1A device in China The device is used to optimise the management of infectious diseases and accurately measures blood flow, cardiac output and...

A fresh decade-low for the dollar ended today’s session on a weak note, leaving Australian markets in the red. Despite attempts to climb against the greenback later in the day, the dollar was worth as little as 66.6 US cents this morning...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

With triple the number of sepsis cases in Australia, small cap biotech company Cynata Therapeutics (ASX:CYP) hopes to wage a new war on blood infections. Last Friday the world learned blood infections were on the rise, with researchers show...

Uscom (UCM) says the China National Medical Administration has certified extended sales of the USCOM 1A device China This certification is valid for five years and is the third consecutive approval for the device This approval allows cur...

Did you know that a hard-working stallion ejaculates 100 times more sperm than the average bloke? Given a virile, but weary, thoroughbred can service hundreds of mares in a breeding season, that’s just as well. But even the most virile of t...

Uscom Limited (ASX: UCM), an innovative medical technology company, has appointed four new US dealers to assist a new US sales and marketing strategy. The appointments of the new dealers assure that they will cover approximately 75% of the...

Ever since the advent of TV, worried parents have cautioned their kids that too much time in front of John Logie Baird’s infernal device will make them go blind – a warning routinely shrugged off by the juvenile couch potatoes. It seems tha...

We hate to sound like an old school report, but it’s been a year of steady and solid progress for the maker of non-invasive cardiac and pulmonary measuring devices, especially in its key target market of China. Achievements include record r...

Uscom Limited (ASX: UCM), an innovative medical technology company, announced the appointment of a new European Sales and marketing Manager, Dr Antonio Ferrario, who will co-ordinate the newly established Uscom sales and marketing hub in Bu...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

The Australian economy is the 14th largest economy in the world and is being awarded a AAA rating by all the three global rating agencies around the world. Since 1992 till 2018, Australia has seen a continuous annual economic growth. Robust...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

Uscom Ltd’s (ASX:UCM) result for the three months to June 30, 2019 featured robust cash receipts with the company finishing fiscal 2019 strongly with June quarter cash income of $780,000, up 47% from $530,000 in the previous corresponding p...

The benchmark index S&P/ASX 200 is trading at 6,665.7 on 10 July 2019 (AEST 01:58 PM), up 0.45%, while the S&P/ASX 200 Health Care Index is up 0.4% to 34,275.1. Let us discuss three healthcare stocks listed on ASX, along with their...